Saturday, October 10, 2026

Raymond James Financial Stock Bearish Momentum With A 16% Fall In The Last 5 Sessions

Raymond James Financial Stock Bearish Momentum With A 16% Fall In The Last 5 Sessions

(VIANEWS) - Shares of Raymond James Financial (NYSE: RJF) slid by a staggering 16.25% in 5 sessions from $107.89 to $90.36 at 13:38 EST on Monday, after four consecutive sessions in a row of losses. NYSE is falling 0.55% to $14,812.29, after two successive sessions in a row of losses.

Raymond James Financial's last close was $94.85, 24.72% below its 52-week high of $126.00.

About Raymond James Financial

Raymond James Financial, Inc., a diversified financial services company, provides private client group, capital markets, asset management, banking, and other services to individuals, corporations, and municipalities in the United States, Canada, and Europe. The Private Client Group segment offers investment services, portfolio management services, insurance and annuity products, and mutual funds; support to third-party product partners, including sales and marketing support, as well as distribution and accounting, and administrative services; margin loans; securities borrowing and lending services; and custodial, trade execution, research, and other support and services. The Capital Markets segment provides investment banking services, including equity underwriting, debt underwriting, and merger and acquisition advisory services; and fixed income and equity brokerage services. The Asset Management segment offers asset management, portfolio management, and related administrative services to retail and institutional clients; and administrative support services, such as record-keeping. The Raymond James Bank segment provides insured deposit accounts; commercial and industrial, commercial real estate (CRE) and CRE construction, tax-exempt, residential mortgage, securities-based, and other loans; loan syndication services; and liquidity management products and services. The Other segment engages in the private equity investments, including invests in third-party funds. The company was founded in 1962 and is headquartered in St. Petersburg, Florida.

Earnings Per Share

As for profitability, Raymond James Financial has a trailing twelve months EPS of $7.49.

PE Ratio

Raymond James Financial has a trailing twelve months price to earnings ratio of 12.07. Meaning, the purchaser of the share is investing $12.07 for every dollar of annual earnings.

The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 17.01%.

Yearly Top and Bottom Value

Raymond James Financial's stock is valued at $90.36 at 13:38 EST, way below its 52-week high of $126.00 and above its 52-week low of $84.86.

Moving Average

Raymond James Financial's value is way under its 50-day moving average of $110.41 and way under its 200-day moving average of $105.78.

Sales Growth

Raymond James Financial's sales growth is 8.9% for the ongoing quarter and 10.7% for the next.

More news about Raymond James Financial (RJF).

ViaNews Editorial Team

Via News Editorial Team delivers comprehensive financial news coverage and market analysis from journalists around the world. Our team specializes in data journalism and in-depth reporting on stock markets, business developments, and economic trends.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Agentic Enterprise Software Consolidates: Big Platforms Push Autonomy While Startups Get Absorbed
Enterprise software is shifting toward autonomous, AI-agent-driven products. SAP (Autonomous Enterprise, Joule), Meta (a new Enterprise Platform led by ex-MongoDB CEO Chirantan Desai) and UiPath (raised guidance) are pushing from the top. Meanwhile AI-security and governance startups are being acquired (Fortinet–Virtue AI, Harvey–Guardrails AI, Tiny–Oso Cloud) and seed-stage agent companies keep raising capital (Dextr, Latitude, Groq). Investors such as Norwest's Sean Jacobsohn see finance and ERP back-office software as the easier area to disrupt. Trust and enforced governance are treated as preconditions for regulated sectors like finance, and AI is judged unreliable for calculations.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,986
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,986 facts checked against source5,366 source documents archived
Query this data → isubstrate.com